Shots: Novo Nordisk to acquire all outstanding shares of Dicerna common stock for $38.25/share in cash making a total equity value of ~$3.3B representing a premium of 80% to Dicerna’s […]readmore
Tags : Acquire
Shots: AcelRx signs a merger agreement to acquire Lowell for $32.5M in cash and an additional ~$26.0M in contingent consideration upon the achievement of regulatory and sales-based milestones, $3.5M in […]readmore
Shots: Organon to acquire Forendo for a total consideration of $954M including $75M up front, $9M in Forendo debt, $270M upon the achievement of development & regulatory milestones & is […]readmore
Shots: Coloplast to acquire Atos Medical for an enterprise value of $2.49B from PAI Partners. The transaction is expected to close in Q2’22 Coloplast obtains access to a new chronic […]readmore
Shots: Ivantis to receive $475M up front along with additional payments upon achievement of regulatory & commercial milestones. The transaction is expected to close in Q1’22 The acquisition expands Alcon’s […]readmore
Shots: Codiak to receive $65M of in-kind manufacturing services for its clinical-stage programs and hold its pipeline of therapeutic candidates along with exosome engineering and loading technologies Lonza will obtain […]readmore
Shots: Takeda is eligible to receive $10M up front in addition to $35M in Calithera Series A preferred stock and is eligible to receive clinical development, regulatory, and sales milestone […]readmore
Shots: Hologic to acquire Bolder Surgical for ~$160M which is a provider of advanced energy vessel sealing surgical devices. The acquisition is expected to be closed by 2021 The transaction will add […]readmore
Shots: Pacira Signs a definitive agreement to acquire Flexion for $8.50/share in cash along with one non-tradeable CVR of ~$8.00/share in cash upon the achievement of sales & regulatory milestones. […]readmore
Shots: Supernus signs a definitive agreement to acquire Adamas for $8.10/ share in cash (~$400M) & 2 non-tradable CVR of ~$1.00 00/share in cash (~$50M) based on sales of GOCOVRI, […]readmore